CIRCE BIOMEDICAL
Circe Biomedical, Inc. develops, produces, and commercializes bioartificial organ systems. It develops bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company also develops PancreAssist System, an implantable, bioartificial pancreas for severe insulin-dependent diabetics. Circe Biomedical, Inc. was incorporated in 1999 and is based in Lexington, Massachusetts.
CIRCE BIOMEDICAL
Industry:
Biotechnology Health Care Medical
Founded:
1999-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.circebio.com
Total Employee:
11+
Status:
Closed
Contact:
(617)863-8720
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Amazon CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Investors List
Polaris Partners
Polaris Partners investment in Private Equity Round - Circe Biomedical
Burrill & Company
Burrill & Company investment in Private Equity Round - Circe Biomedical
HLM Management Company
HLM Management Company investment in Private Equity Round - Circe Biomedical
Advanced Technology Ventures
Advanced Technology Ventures investment in Private Equity Round - Circe Biomedical
Official Site Inspections
http://www.circebio.com
- Host name: 172.67.162.132
- IP address: 172.67.162.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Circe Biomedical"
About us - circ4bio.com
CIRC4BIO platform is foreseen within the frame of LIFE CIRCforBIO project which aims to the substitution of fossil fuels from advanced biofuels and the biomass utilization through the …See details»
Circe: Most Direct Path from CO2 to Products
Circe is reimagining manufacturing. Through advanced gas transformation, we turn CO2 to chemicals at scale. Our platform enables the production of complex, high-performance products, securing the supply chain of essential molecules. …See details»
Circe - LinkedIn
Circe | 2,086 followers on LinkedIn. The great shift in the imbalance | We are building a manufacturing platform that can generate any organic molecule from carbon dioxide, water, and electricity.See details»
About - circe
Circe is reimagining manufacturing. Through advanced gas transformation, we produce carbon-negative molecules at scale. Our platform enables the production of complex, high …See details»
CIRC4BIO | Circ4Bio Supplier Shop
Welcome to the CIRC4BIO platform! Utilizing the CIRC4BIO platform opens up avenues for you to showcase your offerings to a targeted audience. This online marketplace brings together …See details»
Circe Bioscience Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Circe Bioscience Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Circe - Crunchbase Company Profile & Funding
Circe grows their food through fermentation. Using the right fats they make food people want to eat and use CO2 as a feedstock to scale production in an economically viable and climate-friendly way.See details»
News - Circforbio
Presentation of the pilot system to the ELEGTEC Project Consortium partners from Greece, Italy and Indonesia. Researchers from the Unit of Environmental Science and Technology (UEST) …See details»
CIRC4Bio – Advancing Circular Economy in Biomass Refining
CIRC4Bio exemplifies an innovative approach to advancing circular economy principles within the biotechnology sector. Co-funded by LIFE, the EU’s environmental and climate action financial …See details»
Circe 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Circe. Use the PitchBook Platform to explore the full profile.See details»
Circe Bioscience - VentureRadar
Circe Bioscience is pioneering a revolutionary manufacturing platform utilizing fermentation to transform carbon dioxide, water, and electricity into... ... Find out ...See details»
The CIRCforBIO Platform! - Circforbio
Jul 18, 2023 CIRC4BIO platform is foreseen within the frame of LIFE CIRCforBIO project which aims to the substitution of fossil fuels from advanced biofuels and the biomass utilization …See details»
Biomass supplier - circ4bio.com
Welcome to the CIRC4BIO platform! Utilizing the CIRC4BIO platform opens up avenues for you to showcase your offerings to a targeted audience. This online marketplace brings together …See details»
Careers - CIRCE
Circe is reimagining manufacturing. Through advanced gas transformation, we produce carbon-negative molecules at scale.See details»
Circe - Using Carbon Dioxide to Make Fats - Bee Partners
In a future where we make alternatives to delicious things like meat, cheese, ice cream, and butter, we're going to need one very crucial thing – fats. Circe Bioscience has developed …See details»
Technology - CIRCE
Hydrogen drives our process, turning COâ‚‚ into high-performance products. It gives us the flexibility to adapt to a rapidly evolving energy landscape, allowing us to continually optimize …See details»
CIRC4BIO | Circ4Bio Supplier Shop
About Circforbio Biomass to Circular Bio-Fuel and Bio-Products Project Website: https://circforbio.eu The project is co-funded by LIFE, the EU`s financial instrument supporting …See details»
Circe Biomedical Inc - Company Profile and News
Company profile page for Circe Biomedical Inc including stock price, company news, executives, board members, and contact informationSee details»
HiveBio selects 10 startups for first life sciences accelerator ...
3 days ago Here are the members of HiveBio's first cohort for its life sciences accelerator program geared towards underrepresented entrepreneurs.See details»
Circe Biomedical 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Circe Biomedical. Use the PitchBook Platform to explore the full profile.See details»